Human HMGN1 ELISA Kit (V2LY-0626-LY3671)

Yang, C., Ma, Z., Wang, K., Dong, X., Huang, M., Li, Y., ... & Zhang, X. (2023). HMGN1 enhances CRISPR-directed dual-function A-to-G and C-to-G base editing. Nature Communications, 14(1), 2430.

Mao, Y., Yu, J., Da, J., Yu, F., & Zha, Y. (2023). Acteoside alleviates UUO-induced inflammation and fibrosis by regulating the HMGN1/TLR4/TREM1 signaling pathway. PeerJ, 11, e14765.

Page, E. C., Heatley, S. L., Eadie, L. N., McClure, B. J., de Bock, C. E., Omari, S., ... & White, D. L. (2022). HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Oncogene, 41(6), 797-808.

Farley, S. J., Grishok, A., & Zeldich, E. (2022). Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain. Epigenetics & Chromatin, 15(1), 1-27.

Jiang, M., Liu, J., Yang, D., Tross, D., Li, P., Chen, F., ... & Chen, X. (2021). A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer. International Immunopharmacology, 101, 108345.

Chen, C. Y., Ueha, S., Ishiwata, Y., Shichino, S., Yokochi, S., Yang, D., ... & Matsushima, K. (2021). Combining an alarmin HMGN1 peptide with PD-L1 blockade results in robust antitumor effects with a concomitant increase of stem-like/progenitor exhausted CD8+ T cells. Cancer immunology research, 9(10), 1214-1228.

Mehnert, M., Li, W., Wu, C., Salovska, B., & Liu, Y. (2019). Combining rapid data independent acquisition and CRISPR gene deletion for studying potential protein functions: a case of HMGN1. Proteomics, 19(13), 1800438.

Mowery, C. T., Reyes, J. M., Cabal-Hierro, L., Higby, K. J., Karlin, K. L., Wang, J. H., ... & Lane, A. A. (2018). Trisomy of a Down syndrome critical region globally amplifies transcription via HMGN1 overexpression. Cell reports, 25(7), 1898-1911.

Alam, M. M., Yang, D., Trivett, A., Meyer, T. J., & Oppenheim, J. J. (2018). HMGN1 and R848 synergistically activate dendritic cells using multiple signaling pathways. Frontiers in immunology, 9, 2982.

Yang, D., Han, Z., Alam, M. M., & Oppenheim, J. J. (2018, August). High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin. In Seminars in immunology (Vol. 38, pp. 49-53). Academic Press.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols